NEW
Stock Screener with Intrinsic Value
Vertex Pharmaceuticals Incorporated (VRTX)
Last Price$409.9(0.5%)
Market Cap$105.0B
Last Earnings date
Sep'24
Q3 2024
$4.05
134.8% beat
$2,771.9M
4.1% beat
Next quarter EPS Estimate
$4.09
(2.6%)YoY
VRTX Earnings and Expectations
Revenue
Crunching data... Almost there!
VRTX EPS (Earnings Per Share)
Crunching data... Almost there!
VRTX Historical Revenue & EPS and Expectations
Crunching data... Almost there!
VRTX Earnings History
Crunching data... Almost there!
Overview of financial statements
Income statement
Balance sheet
Cash Flow statement
Crunching data... Almost there!
Competing with VRTX Earnings
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Crunching data... Almost there!
Investing armour 2024
50+ visuals to equip yourself with investing wisdom.
Sign up to receive it for FREE
FAQ
1. When was Vertex Pharmaceuticals Incorporated's last earnings date?
Vertex Pharmaceuticals Incorporated's last earnings date was Sep'24 (Q3 2024).
2. What is Vertex Pharmaceuticals Incorporated's EPS, and was there a surprise?
Vertex Pharmaceuticals Incorporated's EPS was $4.05, with a 134.8% beat.
3. What is Vertex Pharmaceuticals Incorporated's revenue, and was there a surprise?
Vertex Pharmaceuticals Incorporated's revenue was $2,771.9M, with a 4.1% beat.
4. What is Vertex Pharmaceuticals Incorporated's next quarter EPS estimate?
Vertex Pharmaceuticals Incorporated's next quarter EPS estimate is $4.09, with an expected (2.6%) YoY growth.